Idorsia Partners with Jamjoom Pharmaceuticals for Insomnia Drug Distribution in Saudi Arabia, Levant

01:32 AM EDT, 07/27/2026 (MT Newswires) -- Idorsia (IDIA.SW) said Monday it is collaborating with Jamjoom Pharmaceuticals Factory (SASE:4015) for the commercialization and distribution of its insomnia drug Quviviq, or daridorexant, in Saudi Arabia and the Levant region in Asia. The Swiss biopharmaceutical group will supply the product, while Jamjoom Pharmaceuticals will secure the marketing authorization for the drug in the jurisdictions covered by the exclusive commercialization agreement. Idorsia will receive an upfront payment and additional payments under the deal.